CTTC — Calmare Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $5.59m
- $1.11m
Annual cashflow statement for Calmare Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2012 December 31st | 2013 December 31st | 2014 December 31st | 2015 December 31st | 2016 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3 | -2.67 | -3.41 | -3.68 | -3.83 |
| Depreciation | |||||
| Non-Cash Items | 0.249 | 0.354 | 0.78 | 0.683 | 0.919 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.37 | 0.74 | 1.55 | 1.45 | 1.66 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -1.37 | -1.57 | -1.06 | -1.53 | -1.24 |
| Capital Expenditures | -0.02 | 0 | -0.046 | -0.005 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.002 | 0 | — | — | — |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.018 | 0 | -0.046 | -0.005 | 0 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.44 | 1.55 | 1.06 | 1.58 | 1.2 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.046 | -0.017 | -0.051 | 0.044 | -0.037 |